A statement from the government said on Friday, "In May 2021, 3,63,000 vials of Amphotericin-B will be imported, thereby resulting in total availability in the country (inclusive of the domestic production) of 5,26752 vials, --3,15,000 vials will be imported in June 2021. along with the domestic supply, the countrywide availability of Amphotericin-B will be enhanced to 5,70,114 vials in June 2021."
Several States and UTs have reported an increasing number of patients suffering from Covid complications in the form of Mucormycosis, popularly known as
The production capacity of the existing companies was extremely limited in the month of April 2021. As a result of the hand-holding by
Union Ministry of Health said five more manufacturers have been given the licence to produce the anti-fungal drug within the country. Cumulatively, these companies will start producing 1,11,000 vials of Amphotericin-B per month from July 2021. The
SEE ALSO
Esper, an Android-based development platform, raises $30 million as pandemic accelerates adoption of intelligent devices
The number of working women in India has been steadily declining, here’s why
Indian government threatens legal action against WhatsApp’s new privacy policy – WhatsApp refuses to back down